Active ingredientTrapidilCat. No. P-T179-001CAS 15421-84-8Family · Pharmaceutical analytical standards
Trapidil
A coronary vasodilator of the triazolopyrimidine family, synthesised in East Germany in the early 1960s and approved in the GDR in 1971 for angina pectoris; it also inhibits platelet aggregation. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Born in Rodleben, behind the Iron Curtain, it made its career mainly in Japan and Italy; it was also studied to prevent the coronary arteries from narrowing again after angioplasty.
Go to the active ingredient →Active ingredientTrapidilCat. No. P-T179-001CAS 15421-84-8
Pharmacopoeial impurityTrapidil EP Impurity ACat. No. P-T179-002CAS 2503-56-2
Impurity3-Amino-1,2,4-TriazoleCat. No. P-T179-003CAS 61-82-5No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceTrapidil CRSEDQM code T1820000Family TrapidilImpurityTrapidil impurity A CRSEDQM code T1820002Family TrapidilImpurityTrapidil impurity B CRSEDQM code T1820004Family TrapidilNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.